Refractory Lymphoid Malignancy
1 clinical trials · Condition
◉ Watch Refractory Lymphoid Malignancy
| Record | Firm | Date |
|---|---|---|
| A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Escalating Doses of AGS67E Given as Monotherapy in Subjects With Refractory or Relapsed Lymphoid Malignancies (NCT02175433) | Astellas Pharma Global Development, Inc. | 2014-10-14 |
Track Refractory Lymphoid Malignancy automatically
Every clearance here is in the API, with alerts when new ones post.